Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs
Immunovia, the diagnostics company that has launched the world’s first blood test dedicated to the […]
The PanDIA-1 Study, for Early Detection of Pancreatic Cancer in Newly Onset Type 2 Diabetics, Moves Into Next Phase
Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly […]
Immunovia Appoints Jeff Borcherding, Previously Chief Marketing Officer at Myriad Genetics, to Lead Immunovia's US Business
Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Jeff Borcherding as CEO of its US subsidiary Immunovia, Inc. He […]
Immunovia Further Strengthens IP Portfolio for its IMMray ™ PanCan-d Signature
Immunovia AB (publ) announced today that the United States Patent and Trademark Office (USPTO) has […]
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more